Cargando…
Identification of Novel Biomarker for Early Detection of Diabetic Nephropathy
Diabetic nephropathy (DN) is one of the most common complications of diabetes mellitus. After development of DN, patients will progress to end-stage renal disease, which is associated with high morbidity and mortality. Here, we developed early-stage diagnostic biomarkers to detect DN as a strategy f...
Autores principales: | Kim, Kyeong-Seok, Lee, Jin-Sol, Park, Jae-Hyeon, Lee, Eun-Young, Moon, Jong-Seok, Lee, Sang-Kyu, Lee, Jong-Sil, Kim, Jung-Hwan, Kim, Hyung-Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146473/ https://www.ncbi.nlm.nih.gov/pubmed/33922243 http://dx.doi.org/10.3390/biomedicines9050457 |
Ejemplares similares
-
Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status
por: Won, Jong Chul, et al.
Publicado: (2018) -
Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy
por: Park, Yeon Su, et al.
Publicado: (2023) -
Dendropanax morbifera Ameliorates Thioacetamide-Induced Hepatic Fibrosis via TGF-β1/Smads Pathways
por: Yang, Hun Yong, et al.
Publicado: (2019) -
Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes
por: Jeon, Yun Kyung, et al.
Publicado: (2011) -
Comprehensive metabolomic profiling in early IgA nephropathy patients reveals urine glycine as a prognostic biomarker
por: Park, Sehoon, et al.
Publicado: (2021)